Angiotensin Receptor Antagonists: all 1,100 studies that test it

Page 7 of 11. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.

• The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/AmlodipineCompletedNCT02387619Phase 1
• Effectiveness of Avapro in Obese Normotensive/Hypertensive African AmericansStatus unknownNCT02386293Phase 2
• Multiple Treatments for Ebola Virus Disease (EVD)Status unknownNCT02380625Phase 1/2
• Lowering Blood Pressure in Primary Care in ViennaCompletedNCT02377661Phase 4
• Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF)TerminatedNCT02373462Phase 4
• A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCompletedNCT02368652Phase 3
• Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)Status unknownNCT02360956Phase 4
• A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and ValsartanCompletedNCT02343250Phase 1
• Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic PatientsCompletedNCT02312375Not applicable
• Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney DiseaseStatus unknownNCT02299310Phase 4
• Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive PatientsCompletedNCT02294539Phase 4
• Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male VolunteersCompletedNCT02263989Phase 1
• Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers IICompletedNCT02262858Phase 1
• Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male SubjectsCompletedNCT02262793Phase 1
• Relative Bioavailability of Telmisartan and SR26334 After Co-administration Compared to the Bioavailability of Telmisartan and SR26334 After Administration of Telmisartan and Clopidogrel Alone in Healthy Male and Female SubjectsCompletedNCT02262650Phase 1
• Bioequivalence of BIBR 277 Tablet (Mannitol Based) Compared With Capsule Formulation in Healthy Male VolunteersCompletedNCT02262585Phase 1
• Bioequivalence of BIBR 277 Tablet Compared With Capsule in Healthy Male VolunteersCompletedNCT02262559Phase 1
• Bioequivalence of Telmisartan Film-coated Tablet Compared With Two Tablets of the Conventional Telmisartan Tablet in Healthy Male VolunteersCompletedNCT02261129Phase 1
• Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy VolunteersCompletedNCT02261116Phase 4
• Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNCT02259829Phase 1
• Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy VolunteersCompletedNCT02259816Phase 1
• Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake PopulationCompletedNCT02255253Not applicable
• Relative Bioavailability Study of Candesartan Cilexetil Under Fasting ConditionsCompletedNCT02254447Phase 1
• Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate HypertensionTerminatedNCT02242812Phase 4
• Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With HypertensionCompletedNCT02242344Phase 2
• Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure MonitoringCompletedNCT02242318Phase 4
• Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure PatientsWithdrawnNCT02238457Phase 4
• Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive PatientsStatus unknownNCT02235519Phase 2/3
• The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCompletedNCT02233218Phase 1
• Efficacy and Safety of Losartan in Children With Ig A NephropathyCompletedNCT02232776Phase 3
• Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular ProteinuriaCompletedNCT02232763Phase 3
• Efficacy and Safety of Abelmoschus Manihot for IgA NephropathyStatus unknownNCT02231125Phase 4
• A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideCompletedNCT02222480Phase 2
• Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male SubjectsCompletedNCT02218684Phase 1
• Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female VolunteersCompletedNCT02215005Phase 1
• Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female VolunteersCompletedNCT02214992Phase 1
• Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female VolunteersCompletedNCT02214979Phase 1
• Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT02213224Phase 4
• the Pharmacokinetic Profiles of Losartan With DW1029MCompletedNCT02212769Phase 1
• Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT02206659Phase 3
• A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionStatus unknownNCT02206165Phase 2
• to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and RosuvastatinCompletedNCT02205190Phase 1
• To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual TabletsCompletedNCT02205151Phase 1
• Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy SubjectsCompletedNCT02203500Phase 1
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200653Phase 4
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200640Phase 4
• Bioequivalence Study of Valsartan 320mg Tablets Under Fed ConditionsCompletedNCT02197494Not applicable
• Bioequivalence Study of Valsartan 320mg Tablets Under Fasting ConditionsCompletedNCT02197442Not applicable
• Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNCT02193308Phase 1
• Residual Renal Function Preservation in Peritoneal Dialysis PatientsStatus unknownNCT02190318Not applicable
• Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy SubjectsCompletedNCT02187536Phase 1
• Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy SubjectsCompletedNCT02187523Phase 1
• BIBR 277 Capsules in Hypertensive Patients With NephropathyCompletedNCT02187484Phase 2
• Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)CompletedNCT02186496Phase 1
• Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential HypertensionCompletedNCT02183701Phase 3
• Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan MonotherapyCompletedNCT02177500Phase 3
• Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate HypertensionCompletedNCT02177487Phase 3
• Telmisartan Compared With Enalapril in Elderly Patients With Blood HypertensionCompletedNCT02177461Phase 4
• BIBR 277 Capsule in Patients With Essential HypertensionCompletedNCT02177448Phase 3
• Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate HypertensionCompletedNCT02177435Phase 3
• Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate HypertensionCompletedNCT02177422Phase 3
• Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate HypertensionCompletedNCT02177409Phase 3
• MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure MonitoringCompletedNCT02177396Phase 3
• Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive PatientsCompletedNCT02172586Phase 4
• Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV InfectionCompletedNCT02170246Phase 1
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and DyslipidemiaCompletedNCT02166814Phase 3
• Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)CompletedNCT02152969Phase 1
• Fimasartan/Amlodipine Combination Phase IIICompletedNCT02152306Phase 3
• Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With HypertensionCompletedNCT02145104Phase 3
• Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With HyperlipidemiaStatus unknownNCT02087540Phase 3
• Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsTerminatedNCT02085265Phase 2
• Pharmacokinetic Drug Interaction Between Candesartan and RosuvastatinCompletedNCT02079506Phase 1
• CKD-330 Drug-Drug Interaction Study (Candesartan)CompletedNCT02064621Phase 1
• Efficacy and Safety of Shenyankangfu Tablets for Primary GlomerulonephritisStatus unknownNCT02063100Phase 4
• A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionStatus unknownNCT02059616Phase 2
• Intermittent Hypoxia 2: Cardiovascular and MetabolismTerminatedNCT02058823Phase 4
• PMS Study of Amlodipine/Valsartan for the Treatment of HypertensionCompletedNCT02058446Phase 4
• Comparative Study of the Effects of Telmisartan and NebivololStatus unknownNCT02057328Phase 4
• CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)CompletedNCT02047175Phase 1
• Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone SystemStatus unknownNCT02010905Phase 2
• Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting ConditionsCompletedNCT02006602Phase 1
• Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting ConditionsCompletedNCT02006589Phase 1
• Non-invasive Haemodynamic Assessment in HypertensionCompletedNCT01996085Not applicable
• Angiotensin II Antagonist in Severe SepsisStatus unknownNCT01992796Phase 3
• Losartan for Sickle Cell Kidney DiseaseCompletedNCT01989078Early Phase 1
• Comparision of Blood Pressure Variability Between Amlodipine and LosartanCompletedNCT01964079Phase 4
• Drug-Drug Interaction Study With PF-05089771CompletedNCT01934569Phase 1
• Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCompletedNCT01926652Phase 1
• To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and RosuvastatinCompletedNCT01921946Phase 1
• Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mgCompletedNCT01918358Phase 1
• Supramaximal Titrated Inhibition of RAAS in Dilated CardiomyopathyCompletedNCT01917149Phase 4
• Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCMCompletedNCT01912534Phase 2
• Drug Interaction Study of Olmesartan in Healthy Chinese VolunteersCompletedNCT01907373Phase 4
• A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT01878201Phase 2
• Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With HypertensionWithdrawnNCT01865188Phase 3
• Pharmacokinetic Interactions of Losartan and HydrochlorothiazideCompletedNCT01858623Not applicable
• Drug Interaction Between Irbesartan and HydrochlorothiazideCompletedNCT01858610Not applicable
• Losartan in Decompensated Heart FailureCompletedNCT01857999Phase 4
• Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for HypertensionCompletedNCT01850160Phase 3
• Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateStatus unknownNCT01845272Phase 1

← Angiotensin Receptor Antagonists overview